The forecast for Canada indicates a steady increase in the number of 10% top-cited scientific publications in Pulmonary and Respiratory Medicine from 2024 to 2028, with values rising from approximately 46.48 to 48.32 publications. The year-on-year growth averages around 1%, highlighting a consistent upward trend. The compound annual growth rate (CAGR) over the forecast period emphasizes a gradual strengthening in research activity and citation impact.
Future trends to watch for include:
- An increased focus on cutting-edge research areas such as respiratory genomics and personalized medicine, potentially boosting publication output.
- Collaborations between Canadian institutions and international entities could escalate the quality and impact of research.
- Government and private funding variations will be crucial in shaping research trajectories and publication volumes.